• FORECEE Logo

    The Project

    The FORECEE research project aims to make individualised risk predictions for cancer available to women for the first time. By looking for molecular markers in cervical cells - taken from a regular smear test - we aim to predict the risk of women developing any one of four cancers: breast, cervical, endometrial and ovarian (the 4Cs).

    The project will run for four years from September 2015.

  • About Us

    Our Funders

    Project Consortium

    The FORECEE consortium is a collaboration of 13 academic institutions and SMEs in 8 countries across Europe. The project is coordinated by Professor Martin Widschwendter at University College London.

  • Take Part

    Six research clinics across Europe are working together to recruit research volunteers to take part in this ground-breaking new study investigating ways to prevent breast, cervical, endometrial and ovarian cancer.

    Samples from approximately 6000 healthy women and women who have already been identified to have a risk factor or one of the 4Cs are needed and we would like to encourage women to participate in this pioneering cancer research.

  • News

    The next face-to-face meeting will take place in October 2016 at the European Institute of Oncology, Milan.

    June 2016: Research Update

  • Media & Publications

    Media

    Links to further information/press materials will be posted here

    Publications

    02/2016: Integration of Genetic and Epigenetic Markers for Risk Stratification (Nora Pashayan et al, Editorial, Personalized Medicine) - View